"Cyn3rgy Research seeks to advance scientific knowledge through clinical research with participation in clinical trials, furthering the advancement of medical treatments and therapies for children as well as adults."

During the past decade, Cyn3rgy Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 18 clinical trials were completed, i.e. on average, 62.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cyn3rgy Research" #1 sponsor was "Sunovion" with 6 trials, followed by "Shire" with 5 trials sponsored, "Incyte Corporation" with 4 trials sponsored, "Sucampo Pharma Americas, LLC" with 3 trials sponsored and "Curemark" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cyn3rgy Research" #1 collaborator was "Sucampo AG" with 2 trials as a collaborator, "AccuDial Pharmaceutical, Inc." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Cyn3rgy Research" are "Atopic Dermatitis" (7 trials), "Attention Deficit Hyperactivity Disorder" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "Autism" (3 trials) and "Constipation - Functional" (3 trials). Many other conditions were trialed in "Cyn3rgy Research" in a lesser frequency.

Most popular intervention types in "Cyn3rgy Research" are "Drug" (34 trials), "Biological" (6 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Lubiprostone" (3 trials), "CM-AT" (2 trials), "Dasotraline" (2 trials) and "FB-401" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cyn3rgy Research" are 44 trials for "All" genders.

Currently, there are NaN active trials in "Cyn3rgy Research". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Cyn3rgy Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cyn3rgy Research, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".